A practical reference on thymosin alpha-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Peptide | 28 amino acid residues |
| Molecular weight | Approximately 3108 Da | Depends on acetylation state |
| N-terminal modification | Acetylated | Affects charge and stability |
| Natural source | Fragment of thymosin beta-4 | Cleaved in vivo |
| Sequence length | 28 residues | Synthetic form matches natural |
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
=== Photosynthetic prokaryotic lineages === Early photosynthetic systems, such as those in green and purple sulfur and green and purple nonsulfur bacteria, are thought to have been anoxygenic, and used various other molecules than water as electron donors. Green and purple sulfur bacteria are thought to have used hydrogen and sulfur as electron donors. Green nonsulfur bacteria used various amino and other organic acids as electron donors. Purple nonsulfur bacteria used a variety of nonspecific organic molecules. The use of these molecules is consistent with the geological evidence that Earth's early atmosphere was highly reducing at that time. With a possible exception of Heimdallarchaeota, photosynthesis is not found in archaea. Haloarchaea are photoheterotrophic; they can absorb energy from the sun, but do not harvest carbon from the atmosphere and are therefore not photosynthetic. Instead of chlorophyll they use rhodopsins, which convert light-energy to ion gradients but cannot mediate electron transfer reactions. In bacteria eight photosynthetic lineages are currently known:
== Personal life == Paul J. Kaesberg was born in Engers district in Germany, on September 26, 1923. In 1926, his parents Gertrude and Peter Kaesberg, moved to the United States of America, and chose to settle in the city of West Bend, Wisconsin. He married Marian L. Kaesberg on June 13, 1953, and the couple had three children.
The science of using computers, databases, and math to organize and analyze large amounts of biological, medical, and health information. Information may come from many sources, including patient statistics, tissue specimens, genetics research, and clinical trials. (NCI) Biological drug
=== 2011 Scottish Parliament election === In January 2011, Galloway launched his campaign in preparation of the May Scottish Parliament election, announcing that he would standing in the Glasgow region. Respect and Solidarity formed an alliance for the election, with Galloway being their top candidate in Glasgow. On the regional ballot, Respect-Solidarity polled 6,972 list votes (3.3%), failing to elect any candidates, though did finish ahead of the Liberal Democrats who lost their seat.
Bukele announced at the Bitcoin 2021 conference on 5 June 2021 that he would introduce a bill to the Legislative Assembly that would make bitcoin legal tender, saying that it would "generate jobs" and promote "financial inclusion" in the short term. The Legislative Assembly approved the bill three days later. Although the World Bank rejected a request from the Salvadoran government to assist it with the implementation of bitcoin as legal tender, citing concerns about transparency and the environmental effects of bitcoin mining, Athena Bitcoin announced that it would invest $1 million to install 1,500 bitcoin ATMs. This would allow users to exchange U.S. dollars for bitcoin and vice versa. Bitcoin became legal tender on 7 September 2021 in El Salvador, the first country to do so. It became legal tender alongside the United States dollar, which had been adopted in 2001 and replaced the Salvadoran colón. About 1,000 people marched in the streets of San Salvador to protest the country's adoption of bitcoin, though other citizens saw the adoption as an "opportunity." According to The New York Times, bitcoin adoption has allowed Salvadorans without bank accounts to "access digital payments, invest savings or boost earnings." The day before bitcoin became legal tender, Bukele announced that the Salvadoran government had bought its first 200 bitcoins. Economist Steve Hanke stated that El Salvador had "the most distressed sovereign debt in the world" due to its adoption of bitcoin, and other economists predicted that the country would likely default on its debt.
Sources: en.wikipedia.org
Artemis II sent four astronauts—including the first woman, person of color, and Canadian—to circumnavigate the Moon. The 2026 FIFA World Cup was held across the U.S., Canada, and Mexico from June to July; and planned events include the 2026 midterms in November.
Tight junctions are very important in embryo development. In the blastula, these cadherin mediated cell interactions are essential to development of epithelium which are most important to paracellular transport, maintenance of cell polarity and the creation of a permeability seal to regulate blastocoel formation. These tight junctions arise after the polarity of epithelial cells is established which sets the foundation for further development and specification. Within the blastula, inner blastomeres are generally non-polar while epithelial cells demonstrate polarity. Mammalian embryos undergo compaction around the 8-cell stage where E-cadherins as well as alpha and beta catenins are expressed. This process makes a ball of embryonic cells which are capable of interacting, rather than a group of diffuse and undifferentiated cells. E-cadherin adhesion defines the apico-basal axis in the developing embryo and turns the embryo from an indistinct ball of cells to a more polarized phenotype which sets the stage for further development into a fully formed blastocyst. Xenopus membrane polarity is established with the first cell cleavage. Amphibian EP-cadherin and XB/U cadherin perform a similar role as E-cadherin in mammals establishing blastomere polarity and solidifying cell-cell interactions which are crucial for further development.
The calculations to be performed on the measurements taken depend on the technology used, since beta counters measure the sample's radioactivity whereas AMS determines the ratio of the three different carbon isotopes in the sample. To determine the age of a sample whose activity has been measured by beta counting, the ratio of its activity to the activity of the standard must be found. To determine this, a blank sample (of old, or dead, carbon) is measured, and a sample of known activity is measured. The additional samples allow errors such as background radiation and systematic errors in the laboratory setup to be detected and corrected for. The most common standard sample material is oxalic acid, such as the HOxII standard, 1,000 lb of which was prepared by the National Institute of Standards and Technology (NIST) in 1977 from French beet harvests. The results from AMS testing are in the form of ratios of 12C, 13C, and 14C, which are used to calculate Fm, the "fraction modern". This is defined as the ratio between the 14C/12C ratio in the sample and the 14C/12C ratio in modern carbon, which is in turn defined as the 14C/12C ratio that would have been measured in 1950 had there been no fossil fuel effect. Both beta counting and AMS results have to be corrected for fractionation. This is necessary because different materials of the same age, which because of fractionation have naturally different 14C/12C ratios, will appear to be of different ages because the 14C/12C ratio is taken as the indicator of age.
Biosimilar insulins, which have a shorter development timeline of about eight years compared to 12 years for novel biologic drugs, provide a more affordable alternative, with development costs ranging from 10% to 20% of those for new biologics. These products could help improve access to treatment and reduce disparities in insulin availability. The global market for biologic medicines, including insulin, grew from $46 billion in 2002 to $390 billion in 2020, accounting for 28% of the global pharmaceutical market. In the United States, biologics represented 43% of drug expenditures, totaling $211 billion in 2019, with biosimilar spending expected to rise from $5.2 billion in 2019 to nearly $27 billion by 2024. In Europe, biologics accounted for 34% of medicine spending, reaching US$78.6 billion in 2021, with the biosimilar market valued at $8.8 billion. The global human insulin market was valued at $22.9 billion in 2020, while the biosimilar insulin market stood at $2.3 billion, projected to grow to $5.6 billion by 2027. The introduction of biosimilar insulins has increased market competition, offering a cost-effective alternative that could lower treatment costs and reduce strain on healthcare systems. Since the approval of the first biosimilar insulin, interest in the products has increased. However, uncertainty regarding their safety and efficacy has slowed their adoption among healthcare professionals.
Sources: en.wikipedia.org
The Philippines acquired 103 P-51D Mustangs after World War II, operated by the 6th "Cobras", 7th "Bulldogs" and 8th "Scorpions" tactical fighter squadrons of the 5th Fighter Wing. These became the backbone of the postwar Philippine Army Air Corps and Philippine Air Force, and were used extensively during the Huk campaign, fighting against communist insurgents, as well as the suppression of Moro rebels led by Hadji Kamlon in southern Philippines until 1955. The Mustangs were also the first aircraft of the Philippine air demonstration team, which was formed in 1953 and given the name the Blue Diamonds the following year. The Mustangs were replaced by 56 F-86 Sabres in the late 1950s, but some were still in service for COIN roles up to the early 1980s. Poland During World War II, five Polish Air Force in Great Britain squadrons used Mustangs. The first Polish unit equipped (7 June 1942) with Mustang Mk Is was "B" Flight of 309 "Ziemi Czerwieńskiej" Squadron (an Army Co-Operation Command unit), followed by "A" Flight in March 1943. Subsequently, 309 Squadron was redesignated a fighter/reconnaissance unit and became part of Fighter Command. On 13 March 1944, 316 "Warszawski" Squadron received their first Mustang Mk IIIs; rearming of the unit was completed by the end of April. By 26 March 1944, 306 "Toruński" Sqn and 315 "Dębliński" Sqn received Mustangs Mk IIIs (the whole operation took 12 days). On 20 October 1944, Mustang Mk Is in 309 Squadron were replaced by Mk IIIs.
=== Ornamental uses === Rhodium finds use in jewelry and for decorations. It is electroplated on white gold and platinum to give it a reflective white surface at time of sale, after which the thin layer wears away with use. This is known as rhodium flashing in the jewelry business. It may also be used in coating sterling silver to protect against tarnish (silver sulfide, Ag2S, produced from atmospheric hydrogen sulfide, H2S). Solid (pure) rhodium jewelry is very rare, more because of the difficulty of fabrication (high melting point and poor malleability) than because of the high price. The high cost ensures that rhodium is typically applied as an electroplate. Rhodium has also been used for honors or to signify elite status, when more commonly used metals such as silver, gold or platinum were deemed insufficient. In 1979 the Guinness Book of World Records gave Paul McCartney a rhodium-plated disc for being history's all-time best-selling songwriter and recording artist and in 2008, Barack Obama gave his wife a rhodium ring.
=== Phytochemicals === Polyphenol phytochemicals present in the fruit, seeds, and leaves are being investigated for their potential biological activities. Major anthocyanins in blackcurrant pomace – delphinidin-3-O-glucoside, delphinidin-3-O-rutinoside, cyanidin-3-O-glucoside, and cyanidin-3-O-rutinoside, which are retained in the juice concentrate – are among other polyphenols.
2,6-Dichloro-1,4-benzoquinone, also known as 2,6-DCBQ, an organic compound that emerges as a disinfection by-product (DBP) that is frequently found in drinking water disinfected with chlorine or chloramines. 2,6-DCBQ is a member of the halobenzoquinones (HBQ), which in recent years has gained significant attention in environmental toxicology due to high levels encountered in drinking water. 2,6-DCBQ has been linked to neurodevelopmental toxicity due to reactive oxygen species formation inhibiting the PI3K/AKT/mTOR pathway. DCBQ does not only have high toxic potency but is also a potential carcinogen. 2,6-DCBQ is frequently used in biochemistry to study the QB-binding site in Photosystem II (PSII). It is used as an artificial electron acceptor (AEAs) with a molecular structure similar to plastoquinone's.
Although his physical endurance is immense, Neo can still be harmed or killed, as evidenced by an injury that Neo suffers while blocking a sword attack with his bare hand. His endurance is also finite: when confronted by masses of Smith clones in the second film, Neo was forced to escape rather than continue fighting though he easily overpowered at least 40 Smith clones and threw about 50 off him, and upon being disconnected from the Matrix, he appeared exhausted and winded. His reflexes are great enough to dodge bullets. Neo's strength and speed level have never been accurately measured; he is known to be capable of Mach 8, at least, and Mach 10 under stress, but his upper limit has never been shown. In the third movie, Neo has reached his (apparent) full strength; he is capable of withstanding a direct physical punch from the Smith enhanced by the Oracle's power, and is also able to hold his own in a prolonged fight (though his endurance is not without limit; he can fight this Smith to a standstill, but not defeat him). In the real world, like the other rebels, Neo does not display any of the aforementioned abilities. According to the Oracle, "The power of The One extends beyond the Matrix.
Sources: en.wikipedia.org
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.
It is usually described as an immunomodulatory peptide rather than a classical hormone. It does not travel to a single distant organ in the manner of an endocrine hormone. Classification varies across sources, and some texts group it with thymic peptides generally.
The broad outline involves immune cell activation, but the specific molecular steps remain under investigation. Different studies report effects on dendritic cells, T cells, and natural killer cells. No single receptor has been confirmed as the sole mediator.
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.